Total Payments
$9,003
2024 Payments
$2,485
Companies
35
Transactions
593
Medicare Patients
8,053
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$8,971 (99.6%)
Education$32.30 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,971 | 588 | 99.6% |
| Education | $32.30 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,016 | 142 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,273 | 95 | $0 (2024) |
| Janssen Biotech, Inc. | $949.14 | 58 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $628.30 | 41 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $466.23 | 26 | $0 (2024) |
| GENZYME CORPORATION | $420.59 | 18 | $0 (2024) |
| Celgene Corporation | $394.53 | 31 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $342.28 | 17 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $254.56 | 18 | $0 (2024) |
| Ardelyx, Inc. | $245.77 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,485 | 138 | ABBVIE INC. ($483.31) |
| 2023 | $1,789 | 105 | ABBVIE INC. ($342.90) |
| 2022 | $1,405 | 95 | ABBVIE INC. ($345.02) |
| 2021 | $797.62 | 54 | AbbVie Inc. ($297.77) |
| 2020 | $541.96 | 35 | Janssen Biotech, Inc. ($125.87) |
| 2019 | $665.28 | 56 | AbbVie, Inc. ($173.39) |
| 2018 | $573.77 | 51 | AbbVie, Inc. ($199.00) |
| 2017 | $745.45 | 59 | Valeant Pharmaceuticals North America LLC ($202.36) |
All Payment Transactions
593 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/22/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.86 | General |
| Category: GI | ||||||
| 12/04/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/24/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/15/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $16.11 | General |
| Category: GI | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $1.27 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,915 | 2,753 | $1.0M | $294,778 |
| 2022 | 16 | 1,879 | 2,832 | $920,165 | $291,024 |
| 2021 | 18 | 1,991 | 3,014 | $967,126 | $320,871 |
| 2020 | 19 | 2,268 | 3,480 | $921,305 | $312,997 |
Total Patients
8,053
Total Services
12,079
Medicare Billing
$1.2M
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 382 | 994 | $188,860 | $84,101 | 44.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 234 | 236 | $197,296 | $45,996 | 23.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 311 | 326 | $140,180 | $31,211 | 22.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 175 | 202 | $73,287 | $25,665 | 35.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 127 | 286 | $32,318 | $17,042 | 52.7% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 27 | 28 | $43,200 | $15,608 | 36.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 89 | 89 | $66,750 | $14,903 | 22.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 111 | 111 | $83,250 | $12,615 | 15.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 91 | 98 | $37,534 | $9,091 | 24.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 55 | 55 | $41,250 | $8,932 | 21.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 70 | 72 | $50,400 | $8,697 | 17.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 36 | 36 | $11,484 | $5,586 | 48.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 37 | 41 | $6,642 | $3,570 | 53.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $8,224 | $2,891 | 35.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 20 | $5,320 | $2,543 | 47.8% |
| 43450 | Dilation of esophagus | Facility | 2023 | 72 | 78 | $10,998 | $2,366 | 21.5% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 19 | 19 | $8,094 | $2,117 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 30 | $4,020 | $1,843 | 45.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 378 | 920 | $174,800 | $79,803 | 45.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 217 | 220 | $183,920 | $42,616 | 23.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 227 | 263 | $83,371 | $37,980 | 45.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 202 | 527 | $59,551 | $28,502 | 47.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 263 | 273 | $117,390 | $26,288 | 22.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 80 | 81 | $60,750 | $14,154 | 23.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 89 | 90 | $67,500 | $10,861 | 16.1% |
About Dr. Amrit Narula, MD
Dr. Amrit Narula, MD is a Internal Medicine healthcare provider based in Pottsville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720050222.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amrit Narula, MD has received a total of $9,003 in payments from pharmaceutical and medical device companies, with $2,485 received in 2024. These payments were reported across 593 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($8,971).
As a Medicare-enrolled provider, Narula has provided services to 8,053 Medicare beneficiaries, totaling 12,079 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Pottsville, PA
- Active Since 02/07/2006
- Last Updated 10/27/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1720050222
Products in Payments
- ENTYVIO (Biological) $783.36
- DUPIXENT (Biological) $762.87
- STELARA (Biological) $716.41
- XIFAXAN (Drug) $604.32
- LINZESS (Drug) $394.44
- ZEPOSIA (Drug) $384.64
- RINVOQ (Biological) $384.00
- SKYRIZI (Biological) $324.35
- Humira (Biological) $277.30
- Linzess (Drug) $254.56
- IBSRELA (Drug) $245.77
- CIMZIA (Drug) $238.38
- Entyvio (Biological) $208.41
- ZENPEP (Drug) $204.61
- XELJANZ (Drug) $193.67
- HUMIRA (Biological) $186.03
- VIBERZI (Drug) $177.36
- REMICADE (Biological) $161.87
- CREON (Drug) $160.74
- SUTAB (Drug) $146.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pottsville
Dr. Cristin Weicker, D.o, D.O
Internal Medicine — Payments: $6,975
Internal Medicine $6,975
Carol Miller-Schaeffer, Md, MD
Internal Medicine — Payments: $6,325
Internal Medicine $6,325
Dr. Dianna Lazur, D.o, D.O
Internal Medicine — Payments: $4,790
Internal Medicine $4,790
Muhammad Munir, Md, MD
Internal Medicine — Payments: $4,194
Internal Medicine $4,194
George Heffner, Md, MD
Internal Medicine — Payments: $4,144
Internal Medicine $4,144
Kimberly Hashin, Md, MD
Internal Medicine — Payments: $3,225
Internal Medicine $3,225